Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Response and Pathomechanism of Purified Tuberculin Unit Protein Injection Therapy for Anogenital Warts with and Without HIV Infection

NCT06587542 is registered in ClinicalTrials.gov with Universitas Padjadjaran as lead sponsor.

NCT NCT06587542
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06587542 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Response and Pathomechanism of Purified Tuberculin Unit Protein Injection Therapy for Anogenital Warts with and Without HIV Infection
Lead sponsor
Universitas Padjadjaran
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
September 15, 2024
Completion date
December 31, 2025
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anogenital warts, hiv infection, tuberculin purified protein derivative